The prospects “the possibilities for domestic pharmaceutical companies to enter into advanced markets”
The prospects that say the possibilities for domestic pharmaceutical companies to enter into advanced markets are growing have come out.
An analyst Hyuntae Kim of Daewoo Securities revealed that Dong-A EST and Celltrion had encouraging results in getting approval from the US and Japan through th...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
